Evidence map›Paper›PMID 34030109›Full record

ReviewInternational journal for parasitology. Drugs and drug resistance2021

Heartworm disease - Overview, intervention, and industry perspective.

Sandra Noack, John Harrington, Douglas S Carithers, Ronald Kaminsky, Paul M Selzer

Abstract readReview
In one paragraph

Review in International journal for parasitology. Drugs and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mapping Global Trends inAnimals : an open access journal from MDPI · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Presence ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  16. Article
  17. Article
  18. Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sandra NoackBoehringer Ingelheim Animal Health, Binger Str. 173, 55216, Ingelheim am Rhein, Germany.
John HarringtonBoehringer Ingelheim Animal Health, 1730 Olympic Drive, 30601, Athens, GA, USA.
Douglas S CarithersBoehringer Ingelheim Animal Health, 3239 Satellite Blvd, 30096, Duluth, GA, USA.
Ronald KaminskyparaC Consulting, Altenstein 13, 79685, Häg-Ehrsberg, Germany.
Paul M SelzerBoehringer Ingelheim Animal Health, Binger Str. 173, 55216, Ingelheim am Rhein, Germany. Electronic address: paul.selzer@boehringer-ingelheim.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dirofilaria immitis, also known as heartworm, is a major parasitic threat for dogs and cats around the world. Because of its impact on the health and welfare of companion animals, heartworm disease is of huge veterinary and economic importance especially in North America, Europe, Asia and Australia. Within the animal health market many different heartworm preventive products are available, all of which contain active components of the same drug class, the macrocyclic lactones. In addition to compliance issues, such as under-dosing or irregular treatment intervals, the occurrence of drug-resistant heartworms within the populations in the Mississippi River areas adds to the failure of preventive treatments. The objective of this review is to provide an overview of the disease, summarize the current disease control measures and highlight potential new avenues and best practices for treatment and prevention.

Indexed as

Cat DiseasesDirofilaria immitisDirofilariasisDog DiseasesAnimalsCatsDogsLactonesLactonesAnimal healthAnthelmintic resistanceDirofilaria immitisHeartworm diseaseMacrocyclic lactonesMechanism of action

Identifiers

PMID34030109
PMCPMC8163879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.